MedPath

Protein, Amino Acids & Insulin & Glucagon Secretion in Humans

Not Applicable
Suspended
Conditions
Metabolic Syndrome
Type 2 Diabetes
Registration Number
NCT01471509
Lead Sponsor
Minneapolis Veterans Affairs Medical Center
Brief Summary

The purpose of this study is to determine the effect of various foods and/or food substances such as fats or proteins on the blood glucose and insulin concentrations in people with and without type 2 diabetes.

Detailed Description

Various foods or food substances are given as a test meal. The metabolic response is determined at various times after the administration of the meal (e.g. blood glucose, and other hormones and metabolites).

Recruitment & Eligibility

Status
SUSPENDED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Subjects with or without type 2 diabetes
  • C-Peptide > 1.5 ng/ml
  • Able to come to the Minneapolis VA Medical Center on several occasions over 2-4 weeks
Exclusion Criteria
  • Body mass index > 40
  • hematologic abnormalities
  • liver disease
  • kidney disease
  • congestive heart failure
  • life threatening malignancies

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Change in blood glucose concentrationseveral time points after ingestion of test substance

Test substances will be given at 0800 hr and blood drawn at several time points up to 5 hours after the meal.

Secondary Outcome Measures
NameTimeMethod
Change in serum insulin concentrationSeveral time points after ingestion of test substance

Test substances will be given at 0800 hr and blood drawn at several time points up to 5 hours after the meal.

Trial Locations

Locations (1)

Minneapolis VA Health Care System

🇺🇸

Minneapolis, Minnesota, United States

Minneapolis VA Health Care System
🇺🇸Minneapolis, Minnesota, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.